Referenslitteratur för:

Cimicifuga racemosa och Remifemin med speciell hänsyn till bröstcancer-problematiken
 
  FÖRFATTARE OCH TIDSKRIFT
PUBLICERAD
HÄMTA PDF
       
  1. Anonymous. Putative pharmacokinetic interactions due to Remifemin.
Inhouse publication, Schaper & Brümmer, 2006.

 2006 Hämta här
  2. Bai W, Henneicke-von Zepelin HH, Wang S, Zheng S, Liu J, Zhang Z, Geng L, Hu L, Jiao C, Liske E. Efficacy and tolerability of a medical product containing an isopropanoloic black cohosh extract in Chinese women with menopausal symptoms: A randomized, double blind, parallel-controlled study versus tibolone.
Maturitas 58; 31-41: 2007

 2007
 Hämta här
  3. Bodinet C, Freudenstein J. Influence of Cimicifuga racemosa on the proliferation of estrogen receptor-positive human breast cancer cells.
Breast Cancer Res Treat, 2002; 76:1–10

 2002 Hämta här
  4. Bodinet C, Freudenstein J. Influence of marketed herbal menopause preparations on MCF-7 cell proliferation.
Menopause 11 (3); 281-289: 2004.

 2004
 Hämta här
  5. Briese V, Stammvitz U, Friede M, Henneicke-von Zepelin HH. Black cohosh with or without St. John’s wort for symptom-specific climacteric treatment – Results of a large-scale, controlled, observational study.
Maturitas 57; 405-414: 2007.

 2007
 Hämta här
  6. Einbond LS, Shimizu M, Xiao D, et al. Growth inhibitory activity of extracts and purified components of black cohosh on human breast cancer cells.
Breast Cancer Research and Treatment 2004; 83: 221‐31.

2004 Hämta här
  7. Fischer J. Är Cimicifuga racemosa ett alternativ för patienter med bröstcancer och klimakteriebesvär?
Posterpublikation 2007. Svensk översättning Per Gruber.

 2007
 Hämta här
  8. Freudenstein J, Dasenbrock C, Nisslein T. Lack of promotion of estrogen-dependent mammary gland tumors in vivo by an isopeopanolic Cimicifuga racemosa extract. Cancer Res, 2002; 62: 3448–352.

 2002 Hämta här
  9. Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Khan IA, Shah A.  In  vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1 and 3A4/5 phenotypes.
Clin Pharmacol Ther 77(5): 415 ‐ 426; 2005.

 2005
 Hämta här
  10. Gurley BJ, Hubbard MA, Williams DK, Thaden J, Tong Y, Gentry WB, Breen P, Carrier DJ, Cheboyina S. Assessing the clinical significance of botanical supplementation on human cytochrome P450 3A activity: comparison of milk thistle and black cohosh product to rifampin and clarithromycin.
J Clin Pharmacol 46(2): 201 ‐ 213; 2006.

2006 Hämta här
  11. Henneicke-von Zepelin HH, Becher H, Schröder-Bernhardi D, Stammwitz U.
Pharmacoepidemiologic Cohort Study on the Administration of Remifemin / Remifemin Plus in Patients with Breast Cancer, Including Hormone Receptor-Positive Tumors.
Annual Meeting of the German Menopause-Society on 17-18 June 2005 in Münster, Germany.

 2005
 Hämta här
  12. Henneicke-von Zepelin HH, Meden H, Kostev K, Schröder-Bernhardi D, Stammwitz U, Becher H.
Isopropanolic black cohosh extract and recurrence-free survival after breast cancer.
Int J Clin Pharm and Therapeutics, vol 45, no 3, pp 143 - 154, 2007.

 2007
 Hämta här
  13. Hernandez Munoz G, Pluchino S. Cimicifuga racemosa for the treatment of hot flushes in women surviving breast cancer.
Maturitas 44, Suppl. 1, pp 59-65; 2003.

2003
  
  14. Hostanska K, Nisslein T, Freudenstein J, Reichling J, Saller R: Cimicifuga racemosa extract inhibits proliferation of estrogen receptor-positive and negative human breast carcinoma cell lines by induction of apoptosis.
Breast Cancer Research and Treatment 84; 151-160: 2004.

 2004
 Hämta här
  15. Hostanska K, Nisslein T, Freudenstein J, Reichling J, Saller R. Evaluation of Cell Death caused by Triterpene Glycosides and Phenolic Substances from Cimicifuga recemosa Extract in Humean MCF-7 Breast Cancer Cells.
Biol Pharm Bull 27 (12); 1970-1975: 2004.

 2004 Hämta här
  16. Hostanska K, Nisslein T, Freundenstein J, Reichling J, Saller R. Apoptosis of Human Prostate Androgen-dependent and –independent Carcinoma Cells induced by an Isopropanolic Extract of Black Cohosh involves Degradation of Cytokeratin (CK) 18.
Anticancer Research 25; 139-148: 2005.

 2005
 Hämta här
  17. Hostanska K, Nisslein T, Freudenstein J, Reichling J, Saller R. Inhibitory effect of an isopropanolic extract of black cohosh on the invasiveness of MDA-MB 231 human breast cancer cells.
In vivo 21; 349-356: 2007.

 2007
 Hämta här
  18. Huntley A, Ernst E. A systematic review of the saftey of black cohosh.
Menopause 10/1; 58–64: 2003

 2003
  
  19. Jacobson JS, Troxel AG, Evans J, et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer.
J Clin Oncol, 2001; 19: 2739–45.

 2001 Hämta här
  20. Lindén-Hirschberg A, Edlund M, Svane G, Azavedo E, Skoog L, von Schoultz B. An isopropanolic extract of black cohosh does not increase ammographic breast density or breast cell proliferation in postmenopausal women.
Menopause 14; 89-96: 2007.

 2007
 Hämta här
  21. Liske E, Häggi W, Henneicke-von Zepelin HH, Boblitz N, Wüstenberg P, Rahlfs VW. Physiological investigation of a unique extract of black cohosh (Cimicifugae racemosae rhizoma): a 6-month clinical study demonstrates no systemic estrogenic effect.
J Womens Health Gend Based Med 11(2); 163 - 174: 2002.

 2001
 Hämta här
  22. Liu J, Burdette JE, Xu H, et al. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symtoms.
J Agric Food Chem 49; 2472–9: 2001.

 2001 Hämta här
  23. Nisslein T, Freudenstein J. Synergistic effects of Black Cohosh and Tamoxifen in an animal model of mammary carcinoma.
Maturitas 44 (Suppl 2) pp. 83-166; 2003.

 2003
 Hämta här
  24. Nisslein T, Freudenstein J.
Coadministration of the Aromatase Inhibitor Formestane and an Isopropanolic Extract of Black Cohosh in a Rat Model of Chemically Induced Mammary Carcinoma.
Planta Med 73: 318-322; 2007.

 2007
 Hämta här
  25. Rebbeck TR, Troxel AB, Norman S, Bunin GR, DeMichele A, Baumgarten M, Berlin M, Schinnar R, Strom L.
A retrospective case-control study of the use of hormone-related supplements and association with breast cancer.
Int J Cancer, 120, 1523 - 1528; 2007.

 2007 Hämta här
  26. Rockwell S, Liu Y, Higgins SA. Alteration of the effects of cancer therapy agents on breast cancer cells by the herbal medicine black cohosh.
Breast Cancer Research and Treatment 90: 233 ‐ 239; 2005.

2005
 Hämta här
  27. von Schoultz B, Henneicke-von Zepelin, HH, Liske E, Friede M, Hirschberg A.
Clinical study on the Drug Safety of Remifemin with regard to Breast Epithelium Cell Proliferation and Mammographic Breast tissue Density in Postmenopausal Women
Annual Meeting of the German Menopause-Society on 17-18 June 2005 in Münster, Germany

 2005
 Hämta här
  28. Stute P, Nisslein T, Götte M, Kamischke A, Kiesel L, Klockenbusch W. Effects of black cohosh on estrogen biosynthesis in normal breast tissue in vitro.
Maturitas 57; 382-391; 2007.

2007 Hämta här
  29. Viereck V, Emons G, Wuttke W. Black cohosh: just another phytoestrogen?
TRENDS in Endocrinology and Metabolism 16 (5); 214-221; 2005.

2005

 Hämta här
  30. Wuttke W, Seidlova-Wuttke D, Gorkow C. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers.
Maturitas 44, Suppl 1; pp. 57-77: 2003.

 2003
 Hämta här
  31. Zierau O, Bodinet C, Kolba S, Wulf M, Vollmer E. Antiestrogenic activities of cimicifuga racemosa extracts.
J Ster Biochem Mol Biol 80: 125–30; 2002.

2002
 Hämta här